MAGT1 and central nervous system cancer: Analysis on the TCGA-GBM and TCGA-LGG datasets unveiled the overexpression of MAGT1 in glioma tissues (Figure 1)), and that on glioma-related GSE140746 microarray indicated higher expression of MAGT1 in glioma tissue after radiotherapy as compared with untreated glioma tissues (Figure 1)).